Ngwa Wilfred, Boateng Francis, Kumar Rajiv, Irvine Darrell J, Formenti Silvia, Ngoma Twalib, Herskind Carsten, Veldwijk Marlon R, Hildenbrand Georg Lars, Hausmann Michael, Wenz Frederik, Hesser Juergen
Department of Radiation Oncology, Dana-Farber Cancer Institute, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts; Department of Physics and Applied Physics, University of Massachusetts, Lowell, Massachusetts.
Department of Radiation Oncology, Dana-Farber Cancer Institute, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts.
Int J Radiat Oncol Biol Phys. 2017 Mar 1;97(3):624-637. doi: 10.1016/j.ijrobp.2016.10.034. Epub 2016 Nov 1.
Radiation therapy (RT) is a crucial component of cancer care, used in the treatment of over 50% of cancer patients. Patients undergoing image guided RT or brachytherapy routinely have inert RT biomaterials implanted into their tumors. The single function of these RT biomaterials is to ensure geometric accuracy during treatment. Recent studies have proposed that the inert biomaterials could be upgraded to "smart" RT biomaterials, designed to do more than 1 function. Such smart biomaterials include next-generation fiducial markers, brachytherapy spacers, and balloon applicators, designed to respond to stimuli and perform additional desirable functions like controlled delivery of therapy-enhancing payloads directly into the tumor subvolume while minimizing normal tissue toxicities. More broadly, smart RT biomaterials may include functionalized nanoparticles that can be activated to boost RT efficacy. This work reviews the rationale for smart RT biomaterials, the state of the art in this emerging cross-disciplinary research area, challenges and opportunities for further research and development, and a purview of potential clinical applications. Applications covered include using smart RT biomaterials for boosting cancer therapy with minimal side effects, combining RT with immunotherapy or chemotherapy, reducing treatment time or health care costs, and other incipient applications.
放射治疗(RT)是癌症治疗的关键组成部分,超过50%的癌症患者在治疗中会用到它。接受图像引导放射治疗或近距离放射治疗的患者通常会在肿瘤中植入惰性放射治疗生物材料。这些放射治疗生物材料的单一功能是确保治疗期间的几何精度。最近的研究提出,可以将惰性生物材料升级为“智能”放射治疗生物材料,其设计功能不止一种。此类智能生物材料包括下一代基准标记物、近距离放射治疗间隔物和球囊施源器,旨在对刺激做出反应并执行其他理想功能,如将增强治疗效果的有效载荷直接可控地递送至肿瘤子体积,同时将正常组织毒性降至最低。更广泛地说,智能放射治疗生物材料可能包括可被激活以提高放射治疗效果的功能化纳米颗粒。本文综述了智能放射治疗生物材料的基本原理、这一新兴跨学科研究领域的现状、进一步研发的挑战与机遇以及潜在临床应用的范围。涵盖的应用包括使用智能放射治疗生物材料以最小的副作用增强癌症治疗、将放射治疗与免疫治疗或化疗相结合、缩短治疗时间或降低医疗成本以及其他初期应用。